📊 Market Recap As of October 8, 2026, 'Moderna, Inc.' (MRNA) closed at $196.48, up +4.81% with an intraday range of $182.50 - $197.69. The stock is now within roughly 7.4% of its 52-week high of $212.22, extending a powerful rally driven by personalized mRNA cancer vaccine data. After-hours trading pushed the price to $195.79, confirming sustained bullish momentum into the next session. 🚀 Key Drivers Cancer Vaccine Catalyst: Phase 3 INTerpath-001 data for intismeran autogene (with Merck's Keytruda) continues to anchor sentiment, with full melanoma results expected on October 24. ESMO Abstracts Accepted: Three abstracts covering melanoma, pancreatic cancer, and early-stage NSCLC were accepted for the European Society for Medical Oncology congress, broadening the pipeline narrative. Analyst

📊 Market Recap As of October 8, 2026, AppLovin Corporation ('APP') closed at $281.29, up +0.90% (+$2.51) on the day. The stock traded in a range of $269.41 – $281.34, with after-hours price at $280.99. The stock now sits just 5.4% above its 52-week low of $266.84, while remaining 61.9% below its 52-week high of $738.01, highlighting a prolonged deep correction with early signs of stabilization. 🚀 Key Drivers Lawsuit Overhang: Multiple law firms have filed securities class actions against AppLovin, alleging misleading statements about AI model improvements and generative AI video tools. The claim period covers February 12 to August 5, 2026, keeping legal uncertainty elevated. Analyst Downgrades: Morgan Stanley, Evercore ISI, and Loop Capital have recently lowered target prices, and BofA dow

📊 Market Recap As of October 8, 2026, 'DRAM' closed at $60.01, up +0.82% for the session. The ETF traded between $57.74 and $60.33, with an amplitude of 4.36%. The closing price sits roughly 26.2% below its 52-week high of $81.34, but remains firmly above its 52-week low of $26.14. After-hours trading pushed the price to $60.05, suggesting sustained buying interest into the evening session. 🚀 Key Drivers Memory Sector Sentiment: As a dedicated memory ETF, 'DRAM' benefits from the broader semiconductor upcycle, with AI-driven demand continuing to support DRAM and NAND pricing expectations. Capital Rotation into Chips: Despite short-term outflows, the five-day capital flow data shows intermittent large-order buying, indicating institutional accumulation attempts near the $55–$58 support zone

📊 Market Recap As of the latest US session, 'BABA' closed at $107.00, down -2.07% from the prior close of $109.26. The stock opened at $106.755 and traded in a narrow range between $106.26 and $107.42, with daily amplitude of just 1.06%. Volume reached 6.99 million shares with a volume ratio of 0.90, indicating mild selling pressure rather than panic distribution. The closing price sits approximately 43% below its 52-week high of $188.66, while remaining about 16% above the 52-week low of $91.99. The stock is currently consolidating below a short-term resistance zone near $115.84 while defending immediate support around $104.87. 🚀 Key Drivers US Treasury Yield Surge: The 10-year Treasury yield rose above 5.365%, hitting its highest level since 2002, pressuring US-listed Chinese ADRs and gr

📊 Market Recap As of October 8, 2026, 'COHR' closed at $334.56, down -1.12% on the day. The stock tested an intraday high of $338.36 but failed to hold gains, settling roughly 24% below its 52-week high of $440.00. The daily range of $316.85 to $338.36 reflects a 6.36% amplitude, suggesting a sharp intraday battle between bulls and bears. Despite the pullback, 'COHR' remains in a strong medium-term uptrend, with the latest pullback appearing to be a healthy consolidation rather than a structural breakdown. 🚀 Key Drivers AI Optics Demand: 'COHR' continues to benefit from surging demand for high-speed optical transceivers used in AI data centers, keeping medium-term growth expectations elevated. Macro Yield Pressure: The 10-year U.S. Treasury yield climbed above 5.365%, its highest since 200

📊 Market Recap As of October 7, 2026, 'ARM' closed at $302.56, down just -0.11% on the day. The stock traded in a narrow range between $301.07 and $308.50, signaling a pause after the explosive AI-infrastructure rally earlier this year. The closing price remains roughly 33% below its 52-week high of $452.70, while support near $206.00 has become a key downside reference after the recent pullback. 🚀 Key Drivers AI Agent CPU Tailwind: ARM architecture is gaining traction as hyperscalers shift computing workloads from GPUs toward custom CPUs for autonomous AI agents; ARM's self-developed CPU for intelligent agents, first adopted by Meta, has been a major catalyst. SoftBank Control & Float Squeeze: SoftBank Group holds approximately 86.39% of shares, leaving a float of only about 143 milli

📊 Market Recap As of the latest U.S. session, 'TSM' settled at $482.30, down -0.72% on the day. The stock remains within 1.1% of its 52-week high of $487.47, consolidating after the October 5 surge that pushed its total market cap near $2.5 trillion. The pullback looks like high-level profit-taking rather than a trend reversal, with a trading range of $481.48 to $486.00 and a modest amplitude of 0.93%. 🚀 Key Drivers Terafab Partnership Speculation: Reports that 'TSM' is in talks to join Elon Musk's Terafab project were confirmed by Musk on X, fueling expectations for end-to-end advanced semiconductor capacity in the U.S. and supporting the record-high breakout. AI Capex Superscycle: Sustained demand for high-end AI chips and aggressive hyperscaler capital expenditure continue to reinforce

📊 Market Recap On October 7, 2026 (ET), 'Moderna, Inc.' closed at $187.46, down -7.75% from the prior close of $203.21. The stock hit an intraday high of $212.22, which marked a new 52-week high, before reversing sharply to a low of $186.64. The close is now about 11.7% below that 52-week high, reflecting intense profit-taking after the recent parabolic rally driven by the personalized mRNA cancer vaccine pipeline. 🚀 Key Drivers Cancer Vaccine Data Momentum: Three abstracts on intismeran autogene were accepted for ESMO, including Phase 3 INTerpath-001 melanoma data; full results are expected on October 24. Rally Overextension: The stock has risen more than 5x year-to-date and more than 100% in the past month, leaving it vulnerable to sharp mean-reversion moves. Short-Selling Pressure: Shor

📊 Market Recap As of the latest session, 'AAPL' closed at $333.63, up +0.22% with a daily gain of $0.74. The stock remains about 3.4% below its 52-week high of $345.34, holding a constructive high-level consolidation after recent leadership changes and renewed positioning in the AI agent ecosystem. 🚀 Key Drivers CEO transition: Reports that Apple's new chief executive is seeking a broad overhaul of the company have kept sentiment active, as investors weigh potential strategic shifts in products and services. AI agent competition: Meta's launch of Muse, which quickly topped the App Store download chart, has refocused attention on Apple's role in the personal intelligent agent race and its services monetization potential. iPhone demand monitoring: UBS noted that iPhone wait times are broadly

📊 Market Recap As of the latest session on October 7, 2026, 'CRCL' closed at $84.13, up 1.00% or $0.83. The stock remains down from its 52-week high of $159.47, but is showing signs of stabilization after rebounding from the $74.45 support level. The recent price action suggests a shift in momentum as buying interest returns near the lower end of its range, with the after-hours quote holding firm at $84.4617. 🚀 Key Drivers Capital Flow Reversal: Five-day capital flow turned positive with consecutive inflows, including 20.57 million on October 1 and 4.41 million on October 5, signaling renewed institutional interest after late-September outflows. Stablecoin Ecosystem Momentum: Circle Internet Corp. remains a key infrastructure play in the digital asset space, with market attention focused o